Our latest updates

DeepX Health’s DermoSight featured on BBC

DeepX Health’s DermoSight at NHS event on 12 July

DeepX Diagnostics Inc.'s DermoSight Receives FDA Clearance for Teledermatology Screening of Suspect Skin Cancer Lesions

DeepX Health’s Skin Cancer Teledermoscopy Services Now in Jersey

New Board Advisor to DeepX Health

New Head of Product at DeepX Health

DeepX Health selected to present at Nordic Life Science Days

Pharmacy Screening Demonstrates Great Efficiency and Potential for Cost Reductions

Primary Care Setting Pilot Launched with NHS

DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin Diseases

ScreenCancer Awarded Support for Diagnostic Triage Algorithm-Project

DeepX Health to participate at the 7th Annual Dermatology Summit in San Francisco

DeepX Health to present at Digital Health World Congress in London

DeepX Health participate in the DxPx Conference

ScreenCancer approved for first round of Horizon 2020 programme